back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-23 11:33 Tx date 2025-11-05 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-5,496 vol |
280,000 | |
| Filed 2025-11-23 11:29 Tx date 2025-11-05 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Subscription Rights Subscription Receipts
36 - Conversion or exchange
|
$-30,000
-50,000 vol $0.60 each |
0 | |
| Filed 2025-11-23 11:28 Tx date 2025-11-05 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Warrants
36 - Conversion or exchange
|
+25,000 vol |
25,000 | |
| Filed 2025-11-23 11:26 Tx date 2021-12-01 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-23 11:24 Tx date 2025-11-05 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Preferred Shares Voting, convertible 1 for 10 common shares
36 - Conversion or exchange
|
$30,000
+50,000 vol $0.60 each |
50,000 | |
| Filed 2025-11-23 11:23 Tx date 2021-12-01 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Preferred Shares Voting, convertible 1 for 10 common shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-23 11:21 Tx date 2025-11-14 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+85,714 vol |
310,714 | |
| Filed 2025-11-23 11:19 Tx date 2025-11-14 |
$AGN
Algernon Health Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$11,999
+171,428 vol $0.07 each |
1,416,428 | |
| Filed 2025-07-29 12:28 Tx date 2025-07-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Control or Direction)
|
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+50,000 vol $0.60 each |
50,000 | |
| Filed 2025-07-29 12:24 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Control or Direction)
|
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-25 12:33 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$41,512
+40,500 vol $1.02 each |
94,000 | |
| Filed 2025-03-25 12:24 Tx date 2025-03-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,245,000 | |
| Filed 2025-03-25 12:23 Tx date 2025-03-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Rights RSUs
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2025-03-25 12:22 Tx date 2025-03-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Rights RSUs
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2025-03-25 12:20 Tx date 2025-01-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-54,000
-40,000 vol $1.35 each |
0 | |
| Filed 2025-03-25 12:20 Tx date 2025-01-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-55,620
-54,000 vol $1.03 each |
40,000 | |
| Filed 2023-03-13 15:27 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$41,512
+40,500 vol $1.02 each |
||
| Filed 2024-09-24 16:41 Tx date 2024-09-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+20,000 vol $0.09 each |
323,492 | |
| Filed 2024-08-07 12:25 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+225,000 vol |
225,000 | |
| Filed 2024-08-07 12:24 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|